Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07146854 · ClinicalTrials.gov registry record
EndoForce Post Approval Study
A clinical trial of End Stage Renal Disease (ESRD), sponsored by Phraxis.
- Recruiting
- Registry status
- 150
- Enrollment target
- 2
- Study locations
NCT07146854: Recruiting study of End Stage Renal Disease (ESRD), sponsored by Phraxis.
NCT07146854 is a study of End Stage Renal Disease (ESRD) that is actively recruiting participants, run by Phraxis. The registered enrollment target is 150 participants, below the 361-participant average among 10 other End Stage Renal Disease (ESRD) trials with a reported enrollment target (58% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07146854, a study of End Stage Renal Disease (ESRD), is actively recruiting participants, sponsored by Phraxis.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this observational study is to collect long-term safety and performance data for the use of the EndoForce System for connecting a hemodialysis graft to a vein in patients with End Stage Renal Disease. This is not an experimental procedure or an experimental therapy. This means that the study device has been approved by the FDA.
Primary Outcome
All device and/or procedure-related events and all major adverse events that reasonably suggest the involvement of the EndoForce and that require or result in any of the following: death, emergent surgery, events requiring hospitalization, events requiring percutaneous interventions, vascular access infection requiring treatment, significant bleeding, pseudoaneurysm and serious adverse events. EndoForce migration, inadequate seal and leakage will also be collected acutely and at each in-person f
Conditions Studied
Study Locations (2)
South Carolina
- MUSC Health Orangeburg - Orangeburg
- Spartanburg Regional Medical Center - Spartanburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-01-13 |
| Est. Completion | 2029-12 |
What NCT07146854 shows while recruiting
NCT07146854 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 361-participant average among 10 other End Stage Renal Disease (ESRD) trials with a reported enrollment target (58% lower).
The record links to 1 condition, with End Stage Renal Disease (ESRD) appearing as the primary indexed condition, and to 0 interventions.
NCT07146854 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT07146854 about?
NCT07146854 is a clinical study titled "EndoForce Post Approval Study". The goal of this observational study is to collect long-term safety and performance data for the use of the EndoForce System for connecting a hemodialysis graft to a vein in patients with End Stage Renal Disease. This is not an experimental procedure or an experimental therapy. This means that the s...
What is the current status of trial NCT07146854?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2026-01-13. Estimated completion is 2029-12.
What conditions does trial NCT07146854 study?
This clinical trial studies the following conditions: End Stage Renal Disease (ESRD).
Who is sponsoring clinical trial NCT07146854?
This trial is sponsored by Phraxis, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07146854 being conducted?
This trial has 2 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease (ESRD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07146854's enrollment target sits among peer trials
150 2nd of 10 higher than 8 of 10 other End Stage Renal Disease (ESRD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End Stage Renal Disease (ESRD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis
RECRUITING · Phase 3
-
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
RECRUITING · NA
-
A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment
ACTIVE NOT RECRUITING · Phase 1
-
Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure
ACTIVE NOT RECRUITING · Phase 1
-
TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI